BSEAGM/EGM4d ago · 7 Aug 2026, 04:27 pm
Notice of 39th Annual General Meeting
IOL Chemicals & Pharmaceuticals Ltd · 524164
✦ AI SummaryMgmt Change
IOL Chemicals & Pharmaceuticals Ltd has announced the notice of its 39th Annual General Meeting (AGM) to be held on September 2, 2026, through video conferencing. The meeting will consider the reappointment of a director, ratify the remuneration of the cost auditor, and adopt the standalone and consolidated audited financial statements for the financial year ended March 31, 2026.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Submission Of Notice Of The 39Th Annual General Meeting
Attachments (1)
📄pdf
Download →
70a17f7e-03d9-4720-8304-786790789974.pdf
View document text
7th August 2026
IOLCP/CGC/2026
National Stock Exchange of India Ltd. BSE Limited
Exchange Plaza, Plot no. C/1, G Block, Phiroze Jeejeebhoy Towers,
Bandra-Kurla Complex, Bandra (E) Dalal Street
Mumbai - 400 051 Mumbai- 400 001
Security Symbol: IOLCP Security Code: 524164
Sub.: Submission of Notice of the 39th Annual General Meeting
Pursuant to Regulation 34 and other applicable provisions of the Securities and Exchange
Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please
find enclosed the Notice of the 39th Annual General Meeting ("AGM") of the Company, which
is scheduled to be held on Wednesday, 2nd September 2026 at 11:30 a.m. (IST) through
Video Conferencing ("VC") / Other Audio-Visual Means ("OAVM").
The AGM Notice forms an integral part of the Company's Integrated Annual Report for the
financial year 2025-26 which is available on the Company’s website at the following link:
https://www.iolcp.com/uploads/Annual_Report_2025-26.pdf
Kindly take the above on record.
Thanking You,
Yours faithfully,
for IOL Chemicals and Pharmaceuticals Limited
Abhay Raj Singh
Sr Vice President & Company Secretary
IOL CHEMICALS AND PHARMACEUTICALS LIMITED
Notice
Integrated Annual Report 2025-26
NOTICE OF ANNUAL GENERAL MEETING
NOTICE is hereby given that the 39th Annual General for re-appointment, be and is hereby re-appointed as a
Meeting (“AGM”) of the Members of IOL Chemicals and Director of the Company, liable to retire by rotation”.
Pharmaceuticals Limited (“the Company”) will be held on
Wednesday, 2nd September 2026, at 11:30 A.M. (IST) through
Special Business:
Video Conferencing (“VC”) / Other Audio-Visual Means
(“OAVM”) to transact the following business: 3. To ratify the remuneration of the Cost Auditor for the
financial year ending 31st March 2027
Ordinary Business: To consider and if thought fit, to pass the following
resolution as an Ordinary Resolution:
1. To receive, consider and adopt the Standalone and
Consolidated Audited Financial Statements of the
“RESOLVED THAT pursuant to the provisions of Section
Company for the financial year ended 31st March 2026
148 and all other applicable provisions, if any, of the
together with Reports of the Board of Directors and
Companies Act, 2013 read with the Companies (Audit
Auditors thereon and in this regard, to consider and
and Auditors) Rules, 2014, (including any statutory
if thought fit, to pass the following resolution as an
modification(s), amendment(s) or re-enactment(s)
Ordinary Resolution:
thereof for the time being in force), the remuneration of
Rs. 2,00,000/- (Rupees Two lakh only), plus applicable
“RESOLVED THAT the Standalone and Consolidated
taxes and reimbursement of out-of-pocket expenses
Audited Financial Statements of the Company for the
actually incurred in connection with the audit, payable to
financial year ended 31st March 2026 together with the
M/s Ramanath Iyer & Co., Cost Accountants, New Delhi
Reports of the Board of Directors and Auditors thereon, as
(Firm Registration No. 000019), appointed by the Board
circulated to the Members, be and are hereby received,
of Directors of the Company on the recommendation
considered and adopted”.
of the Audit Committee as Cost Auditors to conduct
2. To appoint a director in place of Mr. Kushal Kumar Rana, the audit of the cost records of the Company for the
who retires by rotation and being eligible, offers himself financial year ending 31st March 2027, be and is hereby
for re-appointment; and in this regard, to consider ratified and approved”.
and if thought fit, pass the following resolution as an
RESOLVED FURTHER THAT the Board of Directors of the
Ordinary Resolution:
Company (including any Committee thereof) be and is
“RESOLVED THAT pursuant to the provisions of Section hereby authorized to do all such acts, deeds, matters and
152 and other applicable provisions of the Companies things and to take all such steps, as may be necessary,
Act, 2013, Mr. Kushal Kumar Rana (DIN: 09189020), who proper or expedient to give effect to this resolution”.
retires by rotation and being eligible has offered himself
Ludhiana, 20th May 2026 By Order of the Board
Registered Office: for IOL Chemicals and Pharmaceuticals Limited
IOL Chemicals and Pharmaceuticals Limited
CIN: L24116PB1986PLC007030
Village & Post Office - Handiaya, Fatehgarh Chhanna Road, Sd/-
Tehsil & District - Barnala (Punjab)PIN – 148107 Abhay Raj Singh
Ph: 01679-285285, Sr Vice President & Company Secretary
investor@iolcp.com, www.iolcp.com
NOTES:
1) The Explanatory Statement pursuant to Section 102 address is not registered with the Company or with their
of the Companies Act, 2013, which sets out details respective Depository Participant/s, and who wish to
relating to Special Businesses to be transacted at the receive the Notice of the 39th AGM and the Annual Report
Annual General Meeting (AGM) is annexed hereto. for the FY 2025-26 and all other communication sent
Additional information, pursuant to Regulation 36 of the by the Company, from time to time, can get their email
Listing Regulations, in respect of the directors seeking address registered by following the steps as given below:
appointment / reappointment at the AGM, forms part
a) For Members holding shares in physical form,
of this Notice.
please send scan copy of a signed request letter
2) Pursuant to the General Circular No. 3/2025 dated 22nd mentioning your folio number, complete address,
September 2025, issued by the Ministry of Corporate email address to be registered along with scanned
Affairs (MCA) and the circulars issued from time to time by self-attested copy of the PAN and any document
SEBI (hereinafter collectively referred to as “the Circulars”), (such as Driving License, Passport, Bank Statement,
companies are allowed to hold AGM through Video AADHAR) supporting the registered address of
Conferencing (VC) or Other Audio-Visual Means (OAVM), the Member, by email to the Company’s email
without the physical presence of members at a common investor@iolcp.com.
venue. Hence, in compliance with the Circulars, the 39th
b) For the Members holding shares in demat form,
AGM of the Company is being conducted through VC /
please update your email address through your
OAVM facility, without the physical presence of Members at
respective Depository Participant/s.
a common venue. Central Securities Depositories Limited
(‘CDSL’) will be providing facility for voting through remote
8) Notice of AGM is also available on the Company’s website
e-voting, participation in the AGM through VC / OAVM
www.iolcp.com and websites of the Stock Exchanges
facility and e-voting during the AGM. The Registered Office
i.e. BSE Limited and National Stock Exchange of India
of the Company situated at Village & Post Office Handiaya,
Limited at www.bseindia.com and www.nseindia.com
Fatehgarh Channa Road, Barnala – 148107, Punjab (India)
respectively. The Notice of AGM is also disseminated on
shall be deemed to be the venue of the Meeting.
the website of CDSL i.e. www.evotingindia.com.
3) Since this AGM is being held pursuant to the Circulars
9) The Register of Members and Share Transfer Books
through VC / OAVM, physical attendance of Members
of the Company will remain closed from Thursday,
has been dispensed with. Accordingly, the facility for
27th August 2026 to Wednesday, 2nd September
appointment of proxies by the Members will not be
2026 (both days inclusive) for the purpose of the
available for the AGM.
39th Annual General Meeting of the Company.
4) Institutional/Corporate shareholders (i.e. other than
10) To prevent fraudulent transactions, members are advised
individuals, HUF, NRI etc.) are entitled to appoint
to exercise due diligence and notify the Company of any
authorised representatives in terms of Section 113 of
change in address or demise of any member as soon as
the Act to attend the AGM through VC / OAVM and
possible. Members are also advised not to leave their
participate thereat and cast their votes through
[Showing first 8,000 characters — download PDF for full document]